Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

India

 

India’s Covid crisis to peak ‘for another two weeks’

Indian hospitals are struggling and failing to cope with the ruinous COVID-19 wave running rife through the country. As resources dwindle and the international community steps up efforts to assist, HBI talks to an exhausted Delhi-based for-profit hospital operator source who is on the frontlines. He says their modelling predicts another two weeks of intense pressure.
April 28, 2021

Gulf Capital takes re-branded IVI into India

Gulf Capital is taking its Middle East-based IVF platform, acquired from global player IVIRMA last year and now re-branded as ART, into India with the rollout of 18 IVF clinics nationwide. 
March 31, 2021

Max Healthcare raises $165m

India's second-largest for-profit hospital chain Max Healthcare has raised 1,200 crore ($160m) in a Qualified Institutions Placement (QIP), almost the exact same amount as Apollo Hospitals did in January.
March 29, 2021

Metropolis buys big in India, targets further growth

India-based lab group Metropolis Healthcare has bought big in South India, acquiring a network of 31 laboratories and 68 collection centres to its network. The combined entity confirms its position as the second-largest diagnostics company in India and the largest brand in South and West India. Further acquisitions by large Indian diagnostics players are expected.
January 21, 2021

Lockdown and Zoom create cosmetic boom

Demand for aesthetic surgical procedures and cosmetic dentistry is on the rise, fuelled by both a Zoom meeting culture where everyone is aware of their appearance on camera, and the lockdown enabling otherwise undisguisable procedures to remain hidden during recovery.
January 14, 2021

Vaccine tours to claw back medical tourism losses

A handful of medical tourism hubs are starting to organise 'vaccine tours' in a bid to replace lost revenue, HBI hears. The idea is to fly the wealthy to somewhere they can get a COVID-19 jab.
January 14, 2021

HBI 2020: Non-COVID lab volumes recover in Q3 but M&A model may be redundant

Non-COVID lab volumes reached their pre-pandemic levels in Q3. But does the pandemic signal the end of the sector's reliance on M&A, and what are the implications of new B2C markets? Operators Unilabs, amedes, Medicover and Dr Lal Pathlabs, B2C platform Daslab and supplier Abbott discussed all this and more at HBI 2020's 'Diagnostics: Opportunities and Challenges' & 'A new global consumer market?' sessions.
December 21, 2020

HBI 2020: Dentistry – will we see a truly pan-European group and the COVID bounce back?

At the start of this year, there was a lot of optimism around dentistry. The dental sector was seen as one of the biggest and most exciting opportunities for private operators and investors. Largely unconsolidated across Europe and beyond, many asked ‘when will we see a truly pan-European operator'? COVID derailed all expectations of the year but with a vaccine now in play, what are the prospects for consolidation and expansion? HBI 2020 gathered a panel of experts to find out more.
December 21, 2020

Indian inbound medical travel ‘a trickle’ as operators consider costs

Medical travel to India is still 'a trickle' compared to pre-COVID figures although restrictions have also increased the supply of specialists locally, said panellists at HBI's State of the Region's South Asia session. Like elsewhere, the pandemic has forced a re-think of how operators manage costs. 
November 26, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us